| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,166 |
24,745 |
$1.46M |
| 64483 |
|
1,442 |
1,386 |
$245K |
| 64484 |
|
1,409 |
1,352 |
$136K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
481 |
480 |
$46K |
| 80305 |
|
867 |
863 |
$8K |
| 62321 |
|
52 |
51 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
759 |
748 |
$7K |
| 64493 |
|
44 |
40 |
$5K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,051 |
967 |
$5K |
| 64494 |
|
44 |
40 |
$3K |
| 64495 |
|
14 |
13 |
$936.74 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
67 |
67 |
$225.72 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
58 |
57 |
$85.50 |
| 81002 |
|
73 |
73 |
$65.38 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,563 |
1,516 |
$54.54 |
| G8399 |
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed |
1,205 |
1,168 |
$44.48 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
352 |
342 |
$17.21 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,203 |
1,166 |
$17.21 |
| 4004F |
|
268 |
252 |
$0.00 |
| 1006F |
|
904 |
879 |
$0.00 |
| 1036F |
|
2,637 |
2,515 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
76 |
73 |
$0.00 |